On Friday, Caribou Biosciences Inc (NASDAQ: CRBU) opened higher 10.36% from the last session, before settling in for the closing price of $1.93. Price fluctuations for CRBU have ranged from $0.66 to $3.00 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -33.41% annually for the last half of the decade. Company’s average yearly earnings per share was noted 0.06% at the time writing. With a float of $81.90 million, this company’s outstanding shares have now reached $93.12 million.
Caribou Biosciences Inc (CRBU) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Caribou Biosciences Inc is 12.06%, while institutional ownership is 40.84%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.
Caribou Biosciences Inc (CRBU) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.38 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.45) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.99% during the next five years compared to -33.41% drop over the previous five years of trading.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
Check out the current performance indicators for Caribou Biosciences Inc (CRBU). In the past quarter, the stock posted a quick ratio of 6.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Caribou Biosciences Inc (CRBU)
Let’s dig in a bit further. During the last 5-days, its volume was 1.46 million. That was better than the volume of 1.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 76.67%.
During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 72.54%, which indicates a significant decrease from 90.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.94, while its 200-day Moving Average is $1.42. However, in the short run, Caribou Biosciences Inc’s stock first resistance to watch stands at $2.25. Second resistance stands at $2.36. The third major resistance level sits at $2.56. If the price goes on to break the first support level at $1.93, it is likely to go to the next support level at $1.73. The third support level lies at $1.62 if the price breaches the second support level.
Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats
There are currently 93,123K shares outstanding in the company with a market cap of 198.35 million. Presently, the company’s annual sales total 9,990 K according to its annual income of -149,110 K. Last quarter, the company’s sales amounted to 2,670 K and its income totaled -54,100 K.
